Autoantibodies of non‐inflammatory bullous pemphigoid hardly deplete type XVII collagen of keratinocytes

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Experimental Dermatology

• Publication date

  2017-12-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1111/exd.13331PMID 28266727
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Linagliptin‐associated bullous pemphigoid that was most likely caused by IgG autoantibodies against the midportion of BP180

  2017cited by this paper
• Macropinocytosis of type XVII collagen induced by bullous pemphigoid IgG is regulated via protein kinase C

  2016cited by this paper
• Epitope-Dependent Pathogenicity of Antibodies Targeting a Major Bullous Pemphigoid Autoantigen Collagen XVII/BP180.

  2016cited by this paper
• Hemidesmosomes: how much plakins do they need?

  2016cited by this paper
• Autoantibody Profile Differentiates between Inflammatory and Noninflammatory Bullous Pemphigoid.

  2016cited by this paper
• Polymorphisms in the mitochondrially encoded ATP synthase 8 gene are associated with susceptibility to bullous pemphigoid in the German population

  2015cited by this paper
• Heat shock protein 90: a pathophysiological factor and novel treatment target in autoimmune bullous skin diseases

  2015cited by this paper
• Bullous Pemphigoid Autoantibodies Directly Induce Blister Formation without Complement Activation

  2014cited by this paper
• Bullous pemphigoid: role of complement and mechanisms for blister formation within the lamina lucida

  2013cited by this paper
• Pemphigoid diseases.

  2013cited by this paper
• Antibodies to Pathogenic Epitopes on Type XVII Collagen Cause Skin Fragility in a Complement-Dependent and -Independent Manner

  2012cited by this paper
• Carbamazepine-induced toxic effects and HLA-B*1502 screening in Taiwan.

  2011cited by this paper
• IgG from patients with bullous pemphigoid depletes cultured keratinocytes of the 180-kDa bullous pemphigoid antigen (type XVII collagen) and weakens cell attachment.

  2009cited by this paper
• Evaluation of a BP180‐NC16a enzyme‐linked immunosorbent assay in the initial diagnosis of bullous pemphigoid

  2004cited by this paper
• BP180 ELISA using bacterial recombinant NC16a protein as a diagnostic and monitoring tool for bullous pemphigoid.

  2002cited by this paper
• HLA‐DR and DQ polymorphisms in bullous pemphigoid from northern China

  2002cited by this paper
• Autoantibodies to the extracellular and intracellular domain of bullous pemphigoid 180, the putative key autoantigen in bullous pemphigoid, belong predominantly to the IgG1 and IgG4 subclasses

  2001cited by this paper
• Serum levels of autoantibodies to BP180 correlate with disease activity in patients with bullous pemphigoid.

  2000cited by this paper
• Polymorphisms of HLA‐DR and ‐DQ Genes in Japanese Patients with Bullous Pemphigoid

  2000cited by this paper
• Internalization of the 180 kDa bullous pemphigoid antigen as immune complexes in basal keratinocytes: an important early event in blister formation in bullous pemphigoid

  1998cited by this paper
• Immunoreactivity of bullous pemphigoid (BP) autoantibodies against the NC16A and C‐terminal domains of the 180 kDa BP antigen (BP180): immunoblot analysis and enzyme‐linked immunosorbent assay using BP180 recombinant proteins

  1998cited by this paper
• The coupling of α6β4 integrin to Ras–MAP kinase pathways mediated by Shc controls keratinocyte proliferation

  1997cited by this paper
• The coupling of alpha6beta4 integrin to Ras-MAP kinase pathways mediated by Shc controls keratinocyte proliferation.

  1997cited by this paper
• Signal transduction by the alpha 6 beta 4 integrin: distinct beta 4 subunit sites mediate recruitment of Shc/Grb2 and association with the cytoskeleton of hemidesmosomes.

  1995cited by this paper
• Signal transduction by the α6β4 integrin: distinct β4 subunit sites mediate recruitment of Shc/Grb2 and association with the cytoskeleton of hemidesmosomes

  1995cited by this paper
• The role of complement in experimental bullous pemphigoid.

  1995cited by this paper
• Antibody‐Binding to the 180‐kD Bullous Pemphigoid Antigens at the Lateral Cell Surface Causes Their Internalization and Inhibits Their Assembly at the Basal Cell Surface in Cultured Keratinocytes

  1994cited by this paper

• Bullous Pemphigoid Severity and Levels of Antibodies to BP180 and BP230: A Systematic Review and Meta-Analysis.

  2024cites this paper
• The pathological function of neutrophils in pemphigoid diseases

  2024cites this paper
• Differential expression of C5aR1 and C5aR2 in innate and adaptive immune cells located in early skin lesions of bullous pemphigoid patients

  2022cites this paper
• The differences of collagen XVII between the oral mucosa and the skin discover the pathogenesis of oral lesions in pemphigoid

  2020cites this paper
• Fc‐binding proteins enhance autoantibody‐induced BP180 depletion in pemphigoid

  2019cites this paper
• The Diagnosis and Blistering Mechanisms of Mucous Membrane Pemphigoid

  2019cites this paper
• Bullous Pemphigoid IgG Induces Cell Dysfunction and Enhances the Motility of Epidermal Keratinocytes via Rac1/Proteasome Activation

  2019cites this paper
• New Insights Into the Pathogenesis of Bullous Pemphigoid: 2019 Update

  2019cites this paper
• The direct binding of collagen XVII and collagen IV is disrupted by pemphigoid autoantibodies

  2018cites this paper
• Recent advances in the understanding and treatment of pemphigus and pemphigoid

  2018cites this paper
• High Expression of Collagen XVII Compensates for its Depletion Induced by Pemphigoid IgG in the Oral Mucosa.

  2018cites this paper
• Clinical and Immunological Profiles of 14 Patients With Bullous Pemphigoid Without IgG Autoantibodies to the BP180 NC16A Domain

  2018cites this paper
• Complement‐independent blistering mechanisms in bullous pemphigoid

  2017cites this paper
• New insights into pemphigoid diseases

  2017cites this paper
• In vitro and in vivo models to investigate the pathomechanisms and novel treatments for pemphigoid diseases

  2017cites this paper